Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Ann Surg Oncol. 2022 Aug;29(8):5265.
doi: 10.1245/s10434-022-11707-w.
7 General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì, Italy.
8 Peritoneal Malignancies Unit, INT "Regina Elena", Rome, Italy.
9 Peritoneal Surface Malignancy and Soft Tissue Sarcoma Program, University of Messina, Messina, Italy.
10 General and Emergency Surgery Department, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.
11 General Emergency and Trauma Surgery, Bufalini Hospital, Cesena, Italy.
12 General Emergency and Trauma Surgery, Pisa University Hospital, Pisa, Italy.
13 General and Peritoneal Surgery, Department of Surgery, Hospital University Pisa (AOUP), Pisa, Italy.
14 General and Oncological Surgery Unit, AOU of Modena University of Modena and Reggio Emilia, Modena, Italy.
15 Department of Advanced Biomedical Sciences, "Federico II" University, Naples, Italy.
16 Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', Section of Pathology, University of Messina, Messina, Italy.
17 Pathological Anatomy III, Laboratory Medicine Department, Hospital University Pisa (AOUP), Pisa, Italy.
18 Pathology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
19 Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
20 Unit of Surgical Oncology of the Esophagus and Digestive Tract, Surgical Oncology Department, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. antonio.sommariva@iov.veneto.it.